Avestar Capital’s Veracyte VCYT Stock Holding History

Avestar Capital’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-182	Closed	-$5K	–	804
2019 Q2	$5K	Buy	+182	New	+$4.55K	﹤0.01%	586

Other funds holding VCYT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Avestar Capital's VCYT Position: Q3 2019 in Review

Avestar Capital sold out of Veracyte (VCYT) in Q3 2019, closing a stake of 182 shares — an estimated $5K sold.

Avestar Capital first reported a position in VCYT in Q2 2019 and held it in 1 quarter. The position peaked at $5K in Q2 2019. 187 funds tracked by Wall St. Rank hold VCYT as of Q3 2019.

Avestar Capital reported no remaining Veracyte position as of Q3 2019 after selling out during the quarter.
Avestar Capital sold 182 Veracyte shares in Q3 2019, an estimated $5K.
Avestar Capital first reported a position in Veracyte in Q2 2019 and held it in 1 quarter.
Avestar Capital's Veracyte position peaked at $5K in Q2 2019.
187 funds tracked by Wall St. Rank held Veracyte as of Q3 2019.

Based on Avestar Capital's 13F filing for Q3 2019, filed 14 Nov 2019.